BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28431612)

  • 1. Xeroderma pigmentosum complementation group F: A rare cause of cerebellar ataxia with chorea.
    Carré G; Marelli C; Anheim M; Geny C; Renaud M; Rezvani HR; Koenig M; Guissart C; Tranchant C
    J Neurol Sci; 2017 May; 376():198-201. PubMed ID: 28431612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebellar ataxia-dominant phenotype in patients with ERCC4 mutations.
    Doi H; Koyano S; Miyatake S; Nakajima S; Nakazawa Y; Kunii M; Tomita-Katsumoto A; Oda K; Yamaguchi Y; Fukai R; Ikeda S; Kato R; Ogata K; Kubota S; Hayashi N; Takahashi K; Tada M; Tanaka K; Nakashima M; Tsurusaki Y; Miyake N; Saitsu H; Ogi T; Aihara M; Takeuchi H; Matsumoto N; Tanaka F
    J Hum Genet; 2018 Apr; 63(4):417-423. PubMed ID: 29403087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case report: Variants in the
    Kulikowska J; Jakubiuk-Tomaszuk A; Rydzanicz M; Płoski R; Kochanowicz J; Kulakowska A; Kapica-Topczewska K
    Front Genet; 2023; 14():1107460. PubMed ID: 36816046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xeroderma pigmentosum: a rare cause of chorea.
    Adamec D; Xie J; Poisson A; Broussolle E; Thobois S
    Rev Neurol (Paris); 2011 Nov; 167(11):837-40. PubMed ID: 21514943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurological disease in xeroderma pigmentosum: prospective cohort study of its features and progression.
    Garcia-Moreno H; Langbehn DR; Abiona A; Garrood I; Fleszar Z; Manes MA; Morley AMS; Craythorne E; Mohammed S; Henshaw T; Turner S; Naik H; Bodi I; Sarkany RPE; Fassihi H; Lehmann AR; Giunti P
    Brain; 2023 Dec; 146(12):5044-5059. PubMed ID: 38040034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of xeroderma pigmentosum complementation group F with neurological abnormalities.
    Moriwaki S; Nishigori C; Imamura S; Yagi T; Takahashi C; Fujimoto N; Takebe H
    Br J Dermatol; 1993 Jan; 128(1):91-4. PubMed ID: 8427828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurological manifestations in two related xeroderma pigmentosum group D patients: complications of the late-onset type of the juvenile form.
    Stojkovic T; Defebvre L; Quilliet X; Eveno E; Sarasin A; Mezzina M; Destée A
    Mov Disord; 1997 Jul; 12(4):616-9. PubMed ID: 9251090
    [No Abstract]   [Full Text] [Related]  

  • 8. Auditory analysis of xeroderma pigmentosum 1971-2012: hearing function, sun sensitivity and DNA repair predict neurological degeneration.
    Totonchy MB; Tamura D; Pantell MS; Zalewski C; Bradford PT; Merchant SN; Nadol J; Khan SG; Schiffmann R; Pierson TM; Wiggs E; Griffith AJ; DiGiovanna JJ; Kraemer KH; Brewer CC
    Brain; 2013 Jan; 136(Pt 1):194-208. PubMed ID: 23365097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homozygous R788W point mutation in the XPF gene of a patient with xeroderma pigmentosum and late-onset neurologic disease.
    Sijbers AM; van Voorst Vader PC; Snoek JW; Raams A; Jaspers NG; Kleijer WJ
    J Invest Dermatol; 1998 May; 110(5):832-6. PubMed ID: 9579555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative analysis of brain atrophy in patients with xeroderma pigmentosum group A carrying the founder mutation in Japan.
    Ueda T; Kanda F; Nishiyama M; Nishigori C; Toda T
    J Neurol Sci; 2017 Oct; 381():103-106. PubMed ID: 28991657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complex Movement Disorders in Ataxia with Oculomotor Apraxia Type 1: Beyond the Cerebellar Syndrome.
    Pedroso JL; Vale TC; da Costa SCG; Santos M; Alonso I; Barsottini OGP
    Tremor Other Hyperkinet Mov (N Y); 2020 Oct; 10():39. PubMed ID: 33101765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and molecular epidemiological study of xeroderma pigmentosum in China: A case series of 19 patients.
    Zhou EY; Wang H; Lin Z; Xu G; Ma Z; Zhao J; Feng C; Duo L; Yin J; Yang Y
    J Dermatol; 2017 Jan; 44(1):71-75. PubMed ID: 27607234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurological symptoms and natural course of xeroderma pigmentosum.
    Anttinen A; Koulu L; Nikoskelainen E; Portin R; Kurki T; Erkinjuntti M; Jaspers NG; Raams A; Green MH; Lehmann AR; Wing JF; Arlett CF; Marttila RJ
    Brain; 2008 Aug; 131(Pt 8):1979-89. PubMed ID: 18567921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurodegeneration as the presenting symptom in 2 adults with xeroderma pigmentosum complementation group F.
    Shanbhag NM; Geschwind MD; DiGiovanna JJ; Groden C; Godfrey R; Yousefzadeh MJ; Wade EA; Niedernhofer LJ; Malicdan MCV; Kraemer KH; Gahl WA; Toro C
    Neurol Genet; 2018 Jun; 4(3):e240. PubMed ID: 29892709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and genetic characteristics of xeroderma pigmentosum in Nepal.
    Espi P; Parajuli S; Benfodda M; Lebre AS; Paudel U; Grange A; Grybek V; Grange T; Soufir N; Grange F
    J Eur Acad Dermatol Venereol; 2018 May; 32(5):832-839. PubMed ID: 29178624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expansion of the genotypic and phenotypic spectrum of xeroderma pigmentosum in Chinese population.
    Zhang J; Cheng R; Yu X; Sun Z; Li M; Yao Z
    Photodermatol Photoimmunol Photomed; 2017 Jan; 33(1):58-63. PubMed ID: 27982466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole Exome Sequencing allows the identification of two novel groups of Xeroderma pigmentosum in Tunisia, XP-D and XP-E: Impact on molecular diagnosis.
    Ben Rekaya M; Naouali C; Messaoud O; Jones M; Bouyacoub Y; Nagara M; Pippucci T; Jmel H; Chargui M; Jerbi M; Alibi M; Dallali H; Bashamboo A; McElreavey K; Romeo G; Barakat A; Zghal M; Yacoub-Youssef H; Abdelhak S
    J Dermatol Sci; 2018 Feb; 89(2):172-180. PubMed ID: 29169765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predominant neurological phenotype in a Hungarian family with two novel mutations in the XPA gene-case series.
    Zádori D; Szpisjak L; Németh IB; Reisz Z; Kovacs GG; Szépfalusi N; Németh VL; Maróti Z; Tóth-Molnár E; Oláh J; Vécsei L; Klivényi P; Kalmár T
    Neurol Sci; 2020 Jan; 41(1):125-129. PubMed ID: 31478152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutational spectrum of Xeroderma pigmentosum group A in Egyptian patients.
    Amr K; Messaoud O; El Darouti M; Abdelhak S; El-Kamah G
    Gene; 2014 Jan; 533(1):52-6. PubMed ID: 24135642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xeroderma pigmentosum/de sanctis-cacchione syndrome: unusual cause of ataxia.
    Fekete R
    Case Rep Neurol; 2014 Jan; 6(1):83-7. PubMed ID: 24803908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.